Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

30.02CNY
18 Aug 2017
Change (% chg)

¥0.44 (+1.49%)
Prev Close
¥29.58
Open
¥29.49
Day's High
¥30.06
Day's Low
¥29.25
Volume
9,218,805
Avg. Vol
13,476,897
52-wk High
¥33.83
52-wk Low
¥21.49

600196.SS

Chart for 600196.SS

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood... (more)

Overall

Beta: 0.72
Market Cap(Mil.): ¥71,578.60
Shares Outstanding(Mil.): 2,495.17
Dividend: 0.35
Yield (%): 1.08

Financials

  600196.SS Industry Sector
P/E (TTM): 23.90 31.59 32.70
EPS (TTM): 1.24 -- --
ROI: 10.74 15.32 14.88
ROE: 14.02 16.34 16.12

BRIEF-Shanghai Fosun Pharmaceutical clarifies on media reports regarding non-binding proposal

Aug 14 Shanghai Fosun Pharmaceutical Group Co Ltd

Aug 14 2017

BRIEF-Shanghai Fosun Pharmaceutical's unit to bid for US firm Arbor

Aug 14 Shanghai Fosun Pharmaceutical Group Co Ltd

Aug 13 2017

BRIEF-Shanghai Fosun Pharma clarifies on ‍media reports on Gland Pharma acquisition

* Says it have not received notice from India's authorities regarding to its acquisition of Gland Pharma Limited's related matters, clarifying media reports

Aug 03 2017

BRIEF-Shanghai Fosun Pharmaceutical Group says dividend payment date on Aug. 9

* Says it will pay cash dividend of 0.35 yuan per share (before tax) for FY 2016 to shareholders of record on Aug. 8

Aug 02 2017

India raises concerns around Chinese firm Fosun's takeover of Gland-source

India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion takeover of Indian drugmaker Gland Pharma, a source familiar with the matter said on Monday.

Jul 31 2017

UPDATE 2-India raises concerns around Chinese firm Fosun's takeover of Gland-source

* Fosun says closing date of deal extended to Sept. 26 (Adds Fosun chairman's statement in par 5)

Jul 31 2017

BRIEF-Shanghai Fosun Pharmaceutical Group unit receives GMP certificate

July 24 Shanghai Fosun Pharmaceutical Group Co Ltd :

Jul 23 2017

BRIEF-Shanghai Fosun Pharmaceutical announces increase in shareholding by controlling shareholder

July 10 Shanghai Fosun Pharmaceutical Group Co Ltd:

Jul 10 2017

Earnings vs. Estimates